Tag: GLP1-RA

Can GLP-1 Receptor Agonists Help Prevent Amputations? A New National Study from USC Suggests Yes @KeckSchool_USC @USC_Vascular @ALPSlimb #ActAgainstAmputation

GLP‑1 Receptor Agonists and Limb Outcomes: What a 645,000‑Patient Study Tells Us A nationwide retrospective cohort analysis published this week in Diabetes Care explores whether glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) confer advantages over sodium–glucose cotransporter‑2 inhibitors (SGLT2i) for lower‑extremity events in type 2 diabetes. Led by Dr Tze‑Woei Tan, the investigation examined 645,121 individuals newly started on either drug class between... Continue Reading →

0

Physicians Are Healing Themselves—A Reflection on @GinaKolata NYT Article and Our Colleague, Prof. John Buse

Screenshot In a recent New York Times article, Gina Kolata explores a striking trend in modern medicine: physicians, particularly in cardiology and endocrinology, are increasingly turning to GLP-1 receptor agonists like Ozempic, Wegovy, and Zepbound—not just for their patients, but for themselves. The piece highlights how these medications, initially designed to manage diabetes, are now being embraced by medical professionals... Continue Reading →

0

Up ↑

Verified by MonsterInsights